These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 6259660

  • 1. Clinical manifestation of adrenocorticotropin-determined plasma concentrations of mineralocorticoid hormones.
    Biglieri EG, Brust N, Chang B, Hirai J, Wajchenberg BL, Schambelan M.
    Prog Biochem Pharmacol; 1980; 17():36-43. PubMed ID: 6259660
    [Abstract] [Full Text] [Related]

  • 2. Regulation of the mineralocorticoid hormones in adrenocortical disorders with adrenocorticotropin excess.
    Kater CE, Biglieri EG, Brust N, Chang B, Hirai J.
    Clin Exp Hypertens A; 1982; 4(9-10):1749-58. PubMed ID: 6291814
    [Abstract] [Full Text] [Related]

  • 3. Adrenocorticotropin inhibition of mineralocorticoid hormone production.
    Biglieri EG, Chang B, Hirai J, Brust N, Rost CR, Schambelan M.
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():307s-311s. PubMed ID: 232023
    [Abstract] [Full Text] [Related]

  • 4. Plasma renin activity and urinary aldosterone in Cushing's syndrome.
    Mantero F, Armanini D, Boscaro M.
    Horm Metab Res; 1978 Jan; 10(1):65-71. PubMed ID: 204567
    [Abstract] [Full Text] [Related]

  • 5. Circadian secretion of ACTH, cortisol, and mineralocorticoids in Cushing's syndrome.
    Boscaro M, Scaroni C, Masarotto P, Ridolfi P, Benato M, Mantero F.
    Clin Exp Hypertens A; 1982 Jan; 4(9-10):1779-94. PubMed ID: 6291816
    [Abstract] [Full Text] [Related]

  • 6. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
    Kater CE, Biglieri EG, Rost CR, Schambelan M, Hirai J, Chang BC, Brust N.
    J Clin Endocrinol Metab; 1985 Feb; 60(2):225-8. PubMed ID: 2981240
    [Abstract] [Full Text] [Related]

  • 7. Cushing's disease: evaluation of mineralocorticoid-induced hypertension.
    Yasuda G, Shionoiri H, Hayashi S, Umemura S, Ikeda Y, Ishii M.
    Intern Med; 1993 Oct; 32(10):784-8. PubMed ID: 8012073
    [Abstract] [Full Text] [Related]

  • 8. Impaired mineralocorticoid hormone responses to adrenocorticotropin stimulation: additional characterization of heterozygosity for the 21-hydroxylase deficiency type of congenital adrenal hyperplasia.
    Pardini DP, Kater CE, Vieira JG, Biglieri EG.
    J Clin Endocrinol Metab; 1983 Nov; 57(5):1061-6. PubMed ID: 6311859
    [Abstract] [Full Text] [Related]

  • 9. Aldosterone and other mineralocorticoids in Bartter's syndrome.
    Saruta T, Fujimaki M, Senba S, Saito I, Konishi K.
    J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
    [Abstract] [Full Text] [Related]

  • 10. Effects of continued adrenocorticotropin stimulation on the mineralocorticoid hormones in classical and nonclassical simple virilizing types of 21-hydroxylase deficiency.
    Kater CE, Biglieri EG, Wajchenberg B.
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1057-62. PubMed ID: 2987285
    [Abstract] [Full Text] [Related]

  • 11. Radioreceptor assay of plasma mineralocorticoid activity. Role of aldosterone, cortisol, and deoxycorticosterone in various mineralocorticoid-excess states.
    Lan NC, Matulich DT, Stockigt JR, Biglieri EG, New MI, Winter JS, McKenzie JK, Baxter JD.
    Circ Res; 1980 Jun; 46(6 Pt 2):I94-100. PubMed ID: 6991154
    [No Abstract] [Full Text] [Related]

  • 12. Plasma concentration of aldosterone, 18-hydroxy-deoxycorticosterone and cortisol in adrenal veins of patients with low-renin hypertension.
    Horký K, Gregorová I, Tomsová Z, Vancura J, Silinková-Málková E.
    Horm Metab Res; 1977 Sep; 9(5):403-9. PubMed ID: 200537
    [No Abstract] [Full Text] [Related]

  • 13. Concurrent hypercortisolism and hypermineralocorticoidism.
    Hogan MJ, Schambelan M, Biglieri EG.
    Am J Med; 1977 May; 62(5):777-82. PubMed ID: 871129
    [Abstract] [Full Text] [Related]

  • 14. 17 alpha-hydroxylase deficiency: mineralocorticoid hormone profiles in an affected family.
    D'Armiento M, Reda G, Kater C, Shackleton CH, Biglieri EG.
    J Clin Endocrinol Metab; 1983 Apr; 56(4):697-701. PubMed ID: 6300162
    [Abstract] [Full Text] [Related]

  • 15. A case of Cushing's syndrome due to ACTH-independent bilateral macronodular hyperplasia associated with excessive secretion of mineralocorticoids.
    Hayashi Y, Takeda Y, Kaneko K, Koyama H, Aiba M, Ikeda U, Shimada K.
    Endocr J; 1998 Aug; 45(4):485-91. PubMed ID: 9881897
    [Abstract] [Full Text] [Related]

  • 16. Are we missing a mineralocorticoid in teleost fish? Effects of cortisol, deoxycorticosterone and aldosterone on osmoregulation, gill Na+,K+ -ATPase activity and isoform mRNA levels in Atlantic salmon.
    McCormick SD, Regish A, O'Dea MF, Shrimpton JM.
    Gen Comp Endocrinol; 2008 May 15; 157(1):35-40. PubMed ID: 18462736
    [Abstract] [Full Text] [Related]

  • 17. Stimulation and suppression of the mineralocorticoid hormones in normal subjects and adrenocortical disorders.
    Kater CE, Biglieri EG, Brust N, Chang B, Hirai J, Irony I.
    Endocr Rev; 1989 May 15; 10(2):149-64. PubMed ID: 2666117
    [Abstract] [Full Text] [Related]

  • 18. Mineralocorticoid response to low dose adrenocorticotropin infusion.
    Tuck ML, Sowers JR, Asp ND, Viosca SP, Berg G, Mayes DM.
    J Clin Endocrinol Metab; 1981 Mar 15; 52(3):440-6. PubMed ID: 6257748
    [Abstract] [Full Text] [Related]

  • 19. Pseudo-Cushing's syndrome: the role of alcohol.
    Elias AN, Meshkinpour H, Valenta LJ, Grossman MK.
    J Clin Gastroenterol; 1982 Apr 15; 4(2):137-9. PubMed ID: 6282953
    [Abstract] [Full Text] [Related]

  • 20. The mineralocorticoid hormone pathways in hypertension with hyperaldosteronism.
    Biglieri EG, Kater CE, Brust N, Chang B, Hirai J.
    Clin Exp Hypertens A; 1982 Apr 15; 4(9-10):1677-83. PubMed ID: 7139973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.